Consider selective ICU admission based on risk stratification rather than routine admission for all patients.
Low-risk patients (e.g., small supratentorial tumors <2 cm, young healthy patients <50 years without neurological deficits) may be managed with PACU or ward surveillance.
Maintain flexibility to escalate care if intra- or postoperative adverse events occur.
Monitoring & Follow-up
Implement intensive neurological and vital sign monitoring protocols postoperatively, tailored to patient risk and care setting capabilities.
Ensure hourly neurological exams and continuous or frequent vital parameter monitoring when ICU admission is not performed, if feasible.
Risks
Potential for delayed detection of life-threatening neurological complications if ICU admission is omitted without adequate monitoring.
Resource limitations such as ICU bed availability and nurse-to-patient ratios may impact monitoring quality and patient safety.
Legal and institutional standards may influence postoperative care decisions.
Patient & Prescribing Data
1000 consecutive adult patients undergoing elective brain tumor resection at a major academic neurosurgical center
Approximately 92% were admitted to ICU postoperatively; selective criteria excluded young, healthy patients with small tumors from ICU admission; risk scores were evaluated for applicability and safety in guiding ICU admission decisions.
Clinical Best Practices
Use multidisciplinary team judgment (surgeon and anesthesiologist) for postoperative ICU admission decisions.
Apply validated risk prediction models to identify patients who may safely avoid routine ICU admission.
Ensure availability of rapid escalation protocols for patients initially managed outside ICU who develop complications.
Adapt postoperative monitoring intensity to institutional resources and patient risk profile.
Consider cost-efficiency and resource allocation pressures, especially in context of limited ICU capacity.
Over two days, specialists across neurology, neurosurgery and related subspecialties came together to discuss advances in stroke care, epilepsy, movement disorders, neurodegenerative disease, neuro-oncology, brain and spine surgery, interventional pain management and emerging technologies.